ALPMY
Astellas Pharma Inc.
CEO
Kenji Yasukawa
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Loading...
Open
10.88
Mkt cap
20B
Volume
8.3K
High
11.39
P/E Ratio
56.50
52-wk high
13.14
Low
10.88
Div yield
0.04
52-wk low
9.15
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.